Positron emission tomography with 18 fluorodeoxyglucose in acute inflammatory cardiomyopathy
DOI:
https://doi.org/10.37615/retic.v4n3a3Keywords:
Myocarditis, MINOCA, PET, positron emission tomography.Abstract
The diagnosis of acute inflammatory cardiomyopathy can be challenging. Magnetic resonance imaging (MRI) is a key test because it can detect the presence of myocardial edema, hyperemia or fibrosis. Positron emission tomography (PET) could be a more direct way to identify acute inflammatory cardiomyopathy and to quantify the metabolic activity of the disease.
Downloads
Metrics
References
Cooper L, Baughman K, Feldman A, et al. The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease. J Am Coll Cardiol. 2007;50(19):1914-1931.
Chareonthaitawee P, Beanlands R, Chen, et al. Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. Journal of Nuclear Cardiology. 2017;24(5):1741-1758.
Nensa F, Kloth J, Tezgah E, et al. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI. Journal of Nuclear Cardiology. 2016;25(3):785-794.
Takano H, Nakagawa K, Ishio N, et al. Active myocarditis in a patient with chronic active Epstein–Barr virus infection. Int J Cardiol. 2008;130(1).
Nensa F, Poeppel T, Krings P, Schlosser T. Multiparametric assessment of myocarditis using simultaneous positron emission tomography/magnetic resonance imaging. Eur Heart J. 2014;35(32):2173-2173.
Von Olshausen G, Hyafil F, Langwieser N, Laugwitz K, Schwaiger M, Ibrahim T. Detection of Acute Inflammatory Myocarditis in Epstein Barr Virus Infection Using Hybrid 18 F-Fluoro-Deoxyglucose–Positron Emission
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Celia Garilleti Cámara, Luis Javier Ruíz Guerrero, Gonzalo Martín Gorría, Joffrey Eduardo Luján Valencia, Francisco Javier Gómez de la Fuente, Aritz Gil Ongay
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
